Sanofi India Ltd.

SANOFI

Market Cap
₹19,065 Cr.
P/E
31.62

Sanofi India Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Depreciation Effect
Company is depreciating a lower percentage of assets. This is contributing to an increase in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Company is converting accounting profit to cash
Capex vs ROCE
ROCE of the company has increased over the last three years
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years due to earnings
ROE
ROE has decreased vs 10 year trend
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
59.39%
3yr Average
50.15%
5yr Average
37.99%
Net Profit Margin
Latest
21.15%
3yr Average
25.16%
5yr Average
21.09%
ROCE
Latest
38.25%
3yr Average
32.35%
5yr Average
27.35%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
6.24% (as of Jul 22)
Anti - Diabetes - Market Share
0.32% (as of Jul 22)
Anti-Infectives - Market Share
0.05% (as of Mar 19)
Antineo Plastic - Market Share
1.97% (as of Jul 22)
Cardiovascular - Market Share
0.55% (as of Mar 19)
Dermatology - Market Share
1.80% (as of Jul 22)
Gastro-Intestinal - Market Share
2.67% (as of Mar 19)
Neurological - Market Share
2.87% (as of Mar 19)
Pain - Market Share
1.60% (as of Dec 22)
Pharmaceutical Sector - Market Share
3.38% (as of Mar 19)
Respiratory - Market Share
0.10% (as of Mar 19)
Sex Stimulants - Market Share
20.16% (as of Jul 22)
Vaccines - Market Share
0.12% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Allegra
    Avil
    Combiflam
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Sanofi India Ltd.
    View the discussion on ValuePickr
    timeline